LOCALLY ADVANCED UROTHELIAL CARCINOMA

This early-stage trial is testing a new type of immune cell therapy for adults with advanced bladder cancer that has stopped responding to standard treatments. Doctors will give patients specially engineered natural killer (NK) cells designed to recognize and attack cancer cells …

This study is for people with advanced bladder cancer that has spread to a few other areas. It tests if adding surgery or radiation to remove the main tumor and any remaining spots after initial drug therapy helps control the cancer longer. Researchers will track if the cancer gr…

This study is testing a new, personalized vaccine designed to teach the body's immune system to recognize and attack a patient's specific cancer. It is being given alongside an existing immunotherapy drug (pembrolizumab) to adults with advanced solid tumors that have spread. The …

This study is testing whether giving a cancer immunotherapy treatment called nivolumab as an injection at home is a safe and practical alternative to receiving it at a clinic. It aims to see if home treatment reduces the burden of travel and time spent in medical facilities, pote…

This study is for people with advanced bladder cancer that has spread and has stopped responding to a common type of immunotherapy. It aims to see if a new combination of two drugs (pembrolizumab and sacituzumab govitecan) works better and helps people live longer than the curren…

This early-stage study is testing a combination of two drugs, cabozantinib and enfortumab vedotin, for advanced bladder cancer that has spread. The main goal is to find the safest and most effective dose. The study will also look for early signs that the treatment can shrink tumo…